Bull & Lifshitz, LLP Announces Investigation of BioForm Medical, Inc.

Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty and violations of state law in connection with the proposed sale of BioForm Medical, Inc. (Nasdaq:BFRM - News) (referred to as "Bioform" or the “Company”) to Merz Pharma Group.

Bull & Lifshitz, LLP's investigation is focused on whether the proposed deal provides adequate value to the Company’s shareholders.

If you are a holder of BioForm stock and want to discuss your legal rights, you may e-mail or call Bull & Lifshitz, LLP who will, without obligation or cost to you, attempt to answer your questions.

You may contact Peter D. Bull, Esq. or Joshua M. Lifshitz, Esq. at 18 East 41st Street, New York, NY, 10017, by telephone at: (866) 313-6222 or by sending an e-mail including your contact information to: counsel@nyclasslaw.com. All e-mail correspondence should make reference to Bioform.

Bull & Lifshitz, LLP is a New York City-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please visit our website at www.nyclasslaw.com.

Bioform Medical (MM) (NASDAQ:BFRM)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024